Press Release Distribution for the
Biotechnology Industry
Get Featured On
Editorial review included · full 48-hour pickup report · no subscription
★★★★★4.9/5
Trusted by leading biotechnology businesses
Get Your News Featured On Top News Websites
Your release is syndicated across our owned and partner news network — business, industry and regional titles read by your buyers.
Our Packages
Simple one-off pricing — no subscription, no contract. Limited-time launch prices shown.
Was £590 Save £100
- 20+ News Publications
- 100% Google Indexed
- 5-Year Live Link Guarantee
- 3 Categories: Hyperlocal, National & Internet
- SEO-Friendly Backlinks
- 24–72 Hours Average Delivery
Was £3,000 Save £500
- Everything in Essential
- 3 Guaranteed Google News Websites
- 23+ Total News Publications
- 5-Year Live Link Guarantee
- SEO-Friendly Backlinks
- 24–72 Hours Average Delivery
Was £4,000 Save £500
- Everything in Google News PR
- 1 Brand Mention Campaign
- Google News + U.S. Media Distribution
- 5-Year Protected Publication Links
- 2-Year U.S. Media Live Links
- Premium Authority News Coverage
Was £1,500 Save £500
- Premium U.S. Media Distribution
- Multiple American News Websites
- 2-Year Live Link Guarantee
- SEO-Friendly Backlinks
- International Brand Exposure
- 24–72 Hours Average Delivery
Live Biotechnology Media Mentions
Search real-time coverage across trusted news publications from the past 48 hours.
Powered by Newswire Now media monitoring · latest matching coverage from the past 48 hours.
Turn Your Biotechnology News into Headlines
From biotechnology companies and life sciences organisations to research institutes, biotech startups, diagnostics providers, and bioengineering firms, Newswire Now Media Group distributes press releases that increase media visibility, strengthen scientific credibility, and connect your organisation with investors, researchers, healthcare professionals, and industry decision-makers.
Reach Industry Audiences
Distribute your press release to biotechnology publications, life sciences media, healthcare journalists, research platforms, business news outlets, investors, and scientific communities to maximise visibility and industry recognition.
Promote Business & Research Milestones
Share research breakthroughs, product launches, funding announcements, strategic partnerships, clinical developments, laboratory innovations, certifications, and company achievements through professional press release distribution.
Editorially Reviewed Releases
Every press release is professionally reviewed for clarity, accuracy, grammar, and biotechnology terminology, ensuring your scientific and commercial news meets the editorial standards expected by specialist media.
Measure Your Media Impact
Receive detailed distribution reports with publication links, media placements, and campaign insights, helping you track visibility, evaluate campaign performance, and measure the success of every press release.
The News Starts Here
From £490 · live in 48 hours · 500+ publications · no subscription.
Send a Press ReleaseOur Press Releases
Newswire Now Media Group Confirms Verified Placement Reporting Across Its Full Press Release Network
Newswire Now Media Group verifies every press release placement through a documented pickup report, giving businesses…
July 30, 2026
Newswire Now Media Group Launches Guaranteed Google News Placement Package for UK Businesses
Newswire Now Media Group has launched a Google News PR package guaranteeing placement on 3 Google…
July 30, 2026
Newswire Now Media Group Expands Owned Network to 40+ Publications Across UK, US, Europe and Australia
Newswire Now Media Group now owns and operates more than 40 news publications spanning the UK,…
July 30, 2026How We Work
From your submission to media publication in four simple steps — most press releases are distributed within 48 hours.
Submit Your Press Release
Share your press release or key information through our submission form, and our editorial team will prepare it for professional distribution.
Editorial Review
We review, refine, fact-check and optimise your press release to meet professional editorial standards and maximise publication opportunities.
Strategic Distribution
Your press release is distributed to carefully selected media outlets, journalists and news platforms relevant to your industry and target audience.
Distribution Report
Receive a detailed distribution report with publication links and media placements, giving you clear visibility into your campaign's reach and results.
Results We Deliver
Press coverage isn't vanity — it moves buying decisions. The numbers below are drawn from published industry research and our own distribution data.
"Editors don't want advertising, they want evidence. Every release we distribute is built on verifiable facts — that's why our placement rate stays above 98%."
Reach the Right Media with Every Press Release
"Our announcement was covered by 38 outlets, including two national business titles. Enquiries from buyers started the same week."
"They understood our sector instantly. The release read like trade journalism, and editors treated it that way."
"No subscription and a fixed price meant we could test it on one story. That story still brings organic search traffic months later."
Latest Insights
Frequently Asked Questions
How does press release distribution benefit biotechnology companies?
Press release distribution helps biotechnology companies increase visibility, strengthen credibility and communicate scientific achievements to investors, researchers, partners and industry stakeholders. Professional media coverage helps organisations explain important developments while building recognition within a competitive innovation environment. Newswire Now Media Group ensures biotechnology announcements reach audiences interested in scientific progress and commercial opportunities.
Can you distribute biotechnology research announcements?
Yes, Newswire Now Media Group distributes biotechnology research announcements covering discoveries, collaborations, scientific reports and innovation developments. Research achievements require accurate communication to reach relevant scientific and commercial audiences. Strategic distribution helps increase awareness while maintaining professional standards.
Do you work with biotechnology innovation organisations?
Yes, Newswire Now Media Group supports biotechnology innovation organisations by promoting research achievements, technology developments and commercial milestones through targeted media campaigns. We help innovation-focused businesses communicate their value to investors, partners and industry professionals.
Can biotechnology reports be promoted through press releases?
Yes, biotechnology reports and research insights can be promoted through professional press release distribution to increase awareness among relevant industry audiences. Reports provide valuable opportunities to demonstrate expertise, share findings and contribute to industry discussions.
Can press releases help biotechnology organisations attract talent?
Yes, press releases support biotechnology recruitment by increasing employer visibility and highlighting research opportunities, company growth and innovation-focused careers. Organisations developing advanced technologies require skilled professionals, and media exposure helps communicate career opportunities within the sector.
What is the scope of biotechnology PR?
The scope of biotechnology PR includes communicating research, innovation, partnerships, investments, recruitment and business developments across healthcare, agriculture, environmental science and life science sectors. Professional PR helps biotechnology organisations build trust and visibility among audiences that influence growth.
Why is specialist biotechnology PR better than general press release distribution?
Specialist biotechnology PR provides industry-focused communication that understands scientific terminology, research objectives and the commercial importance of biotechnology developments. Newswire Now Media Group creates campaigns designed around the specific needs of biotechnology organisations rather than using generic messaging.